Patent Assignment
Reel/Frame 058437/0351
Assignment of Assignor's Interest
Recorded: 2021-12-20
Pages: 6
Assignee
HUMANIGEN, INC.
533 AIRPORT BOULEVARD, SUITE 400, BURLINGAME, CALIFORNIA, 94010
Covered Property
(1)
Methods of Treating Immunotherapy-Related Toxicity Using Lenzilumab
Application:
17/274,167 →
Publication:
US 2021/0290677
Related Assignments
(2)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest
Apr 29, 2024
From: HUMANIGEN, INC.
To: TARAN THERAPEUTICS, INC.
Reel/Frame 067259/0528 →
Corrective Assignment to Correct the the Attorney Docket No. from P-588788-Us to P-566450-US15NCIP, P-566450-US15N; P566450-US15D Previously Recorded at Reel: 67259 Frame: 528. Assignor(S) Hereby Confirms the Assignment.
Jun 11, 2024
From: HUMANIGEN, INC.
To: TARAN THERAPEUTICS, INC.
Reel/Frame 067718/0834 →